Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Adherium Ltd. ( (AU:ADR) ) has issued an announcement.
Adherium Limited has issued 66,208,082 fully paid ordinary shares without disclosure to investors under the Corporations Act 2001. The company confirms compliance with relevant provisions of the Act and states there is no excluded information required to be disclosed. This announcement reflects Adherium’s ongoing commitment to maintaining transparency and regulatory compliance, which may impact its market positioning and stakeholder confidence.
More about Adherium Ltd.
Adherium is a leader in connected respiratory medical devices and provides integrated digital health solutions. Its Hailie® platform allows clinicians, healthcare providers, and patients to remotely monitor medication usage and adherence, facilitating reimbursement for patient management. The platform includes tools for data capture and sharing via apps, SDK, and API integration, along with a range of sensors for respiratory medications.
Technical Sentiment Signal: Sell
Current Market Cap: A$8.98M
For a thorough assessment of ADR stock, go to TipRanks’ Stock Analysis page.